Antegenes provides innovative genetic tests for assessing your polygenetic risk of breast cancer, prostate cancer, colorectal cancer and melanoma. These tests provide an approach for preventative action before the disease and can be ordered either individually through our website or from authorized resellers.
Our tests take into account your unique characteristics: epidemiologic background, genetic composition, sex and age; which make your results fully personalized.
The tests can be performed for all adults. Each test has a designated age group containing individuals with the largest expected benefits.
Tests can be ordered through the Antegenes website. The tests can be bought for yourself and also for others.
If you have previously purchased at least one test then we can use a previously collected DNA sample to process additional tests. Please provide an order for additional tests via the MyAntegenes portal.
Antegenes tests are not designed for individuals under 18 years of age.
Testing age cut-offs have been set based on when the age-related 10-year likelihood of developing a disease starts to become clinically relevant. For younger individuals, any recommendations may be placed to happen long in the future so we believe that it is unnecessary to potentially cause distress by delivering results without actionable follow-ups.
However, with patients’ discretion Antegenes test can be provided for all adults as regardless of age as DNA stays largely unchanged throughout life.
We offer an online healthcare service. If you ordered a test with a DNA-testing kit then we need you to collect a DNA sample with a sampling kit sent at your address and return it to us.
Additionally, we will provide intuitive explanations to guide you through some steps required to manage your order online in the MyAntegenes portal which should not take more than a few minutes.
Identity verification via Veriff or other type of electronic identification (mobile-ID, smartID, ID card).
Personalization of your profile.
Review of a test based informed consent form.
Processing of genetic data and provision of a healthcare service requires your informed consent. The patient’s informed consent form gives you an overview of the test, the purpose and its limitations. Its aim is to register your informed consent of being provided this service. The informed consent form can be reviewed in the MyAntegenes portal.
First, you will be opened a MyAntegenes account that allows you complete the steps required for personalizing your order.
All steps are completed individually online and should not take more than a few minutes:
Identity verification via Veriff or other type of electronic identification (mobile-ID, smartID, ID card).
Personalization of your profile.
Review of a test based informed consent form.
At the same time, Antegenes will send all DNA testing kits assembled to the address specified in checkout. Upon arrival, these are to be distributed among the recipients. Each kit contains instructions of use. After collecting the DNA sample, it must be returned returned by following the instructions in the kit.
After sample return, your sample will be sent for analysis in the genotyping laboratory. These data will be next used to perform your genetic risk analysis and test results will be made available through your personal MyAntegenes account.
Your DNA test kit is sent either via parcel machine (Itella Smartpost) in Estonia or other shipping options depending on your location.
Each DNA-testing kit comes with everything needed for taking your DNA sample. Please follow the sample collection instructions in the kit to take the sample and then place the box inside the courier bag that came with the kit. The test can be returned for free via the parcel machine (Estonia) or a different agreement depending on the instructions of return included in your kit.
If you retrieved your sample collection kit via a parcel machine (Estonia) then please resubmit your sample in 14 days during which the return is free of charge. In any other case, it is reasonable to resubmit as fast as possible but in no later than 12 months.
If 14 days has passed from the time you received the test kit, you will need to pay for the return costs. If you are using a parcel machine to return the sample, please start a new parcel delivery process (detailed instructions are available at parcel machines). Please send your sample to Tartu Tasku parcel machine (Omniva, Itella Smartpost or DPD).
Recipient’s name: Antegenes
Phone number: +372 5377 8141.
It is also possible to bring your sample directly to Antegenes Laboratory between Mon-Fri from 9 am to 5 pm. Our address is Raatuse 21, Tartu.
Please write us about your concern at info@antegenes.com or call +372 5377 8141.
If your collection kit is damaged or has expired, we will send you a replacement kit free of charge. You can request a new test kit by contacting us at info@antegenes.com or call +372 5377 8141.
All test results are reviewed by our laboratory physician.
Results from tests with DNA-testing kit will be ready in about 6 weeks from the time your sample is received at the lab.
Results from tests with DNA data upload are expected to be ready in approximately 1 week from the upload of your DNA data.
Test results will be made available through your personal MyAntegenes account. You will receive a notification via e-mail when the reports are ready.
Antegenes provides genetic counseling for its tests as an additional service. All counseling sessions take place online or by telephone during which a qualified healthcare professional explains you your results. We also recommend you to take an opportunity to complete an additional test specific questionnaire in MyAntegenes prior to the consultation.
Session duration is around 20 minutes.
Post-test genetic counseling can be either included in the order in the initial purchase or at any point during your order processing through your MyAntegenes account.
If you have purchased a genetic consultation and Antegenes has made at least one test results available to you then it would be possible to register for an online genetic counseling either through your MyAntegenes account or by contacting us using the details below.
At the time of the online registration, choose a time from the openings and enter any requested information. After registration, you will be sent detailed instructions about the course of the session.
Antegenes is a healthcare provider of laboratory medicine, medical genetics and outpatient oncology registered with the Estonian Health Board (license L05386). All our genetic tests are registered as medical devices and CE-marked (IVDD; 98/79 / EC). Our data management complies with GDPR requirements (privacy policy) and all operational processes are designed according to the ISO13485 quality management standard.
We strive to provide an online service that is as convenient as possible. All required activities can be managed online – privately and conveniently without leaving home.
For patients, the provision of tests within the healthcare system only means that Antegenes services comply with all the European Union laws regarding health and genetic data. Test results are also recorded in the digital Estonian Health Information System.
Your DNA sample will be analyzed with a technology called genotyping. This entails extracting the DNA from the sample and making it into analyzable data. We perform genotyping only in laboratories in the European Union. Laboratories only receive pseudonymized samples, ie. you can not be directly identified. Genotyped data will be further used to conduct your risk analysis.
Your physical DNA sample is destroyed after completion of the analysis.
Antegenes processes and handles personal data only for specified purposes in accordance with valid legislation. Antegenes does not transmit any personal or health data to parties not directly taking part in providing your ordered service.
All details regarding data handling and its privacy are laid out in our Privacy policy.
Antegenes tests use the polygenic risk score (PRS) approach. PRS is a computational metric that aggregates carrier information from genetic variants to characterize an individual’s predisposition to a studied condition.
Polygenic risk scores can combine information from any number of (risk increasing and lowering) variants to provide an overall estimate. Each individual genetic variant has little effect on the overall risk of the condition, but combining the effects of the individual variants contributes to a clinically significant assessment of the overall disease development risk.
Genotyping is a technology that is used to identify the status of known single nucleotide polymorphisms (SNPs) located all over the genome that are expected to vary between individuals and can thus assume many different states.
